Fieldview Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Fieldview Capital Management's BSX Position: Q3 2026 in Review
Fieldview Capital Management reduced its Boston Scientific (BSX) stake by 3.7% in Q3 2026, selling an estimated $31.5K and leaving 17,626 shares worth $769K. The position accounts for 0.22% of the portfolio, ranked #144.
Fieldview Capital Management first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.34M in Q3 2025. 1,504 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Fieldview Capital Management held 17,626 shares of Boston Scientific worth $769K as of Q3 2026.
- Fieldview Capital Management sold 680 Boston Scientific shares in Q3 2026, an estimated $31.5K.
- Boston Scientific made up 0.22% of Fieldview Capital Management's portfolio in Q3 2026, its #144 holding.
- Fieldview Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
- Fieldview Capital Management's Boston Scientific position peaked at $5.34M in Q3 2025.
- 1,504 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Fieldview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.